Delivery Order SPE2DB22D3301-SPE2DB24FX4ZM
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,749.68 for pharmaceutical and medical supply products. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The IDC enables the DLA to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,467.15 for pharmaceutical and medical supply distribution. The award was made by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. The contract covers a comprehensive range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
- This federal contract award, valued at $1,849.24, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the provision of pharmaceutical products and medical supplies to support military healthcare programs and facilities. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This federal contract award to Amerisourcebergen Drug Corp., a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,761.15 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00. The IDC, which runs through November 2026, enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order awarded by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment...
- This federal contract award, valued at $2,485.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical devices, to support military treatment facilities and veterans' healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This includes specialty medications, brand-name and...
- This federal contract award, valued at $1,433.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical devices, to support military treatment facilities and Department of Defense...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract is with the Defense Logistics Agency (DLA), a defense agency, to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FX4ZMDelivery Order
This federal contract award, valued at $1,699.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order that provides various pharmaceutical products, including capsules, to support military healthcare programs. The award has an ultimate completion date of November 7, 2023 and is a firm fixed price contract. This appears to be part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract was awarded through full and open competition and does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/6/23 |